Back to Peptides

GHRP-6

Well Studied

Growth Hormone Releasing Peptide-6 | Hexapeptide GHS

Dose 100-300 mcg per injection
Frequency 2-3 times daily (morning, post-workout optional, before bed)
Cycle 8-12 weeks
Storage Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 28 days
Accumulation Plotter

GHRP-6 is a synthetic growth hormone secretagogue that stimulates the pituitary gland to release growth hormone. It was one of the first GHRPs developed and works by binding to the ghrelin receptor (GHS-R1a). Unlike direct HGH injections, GHRP-6 enhances the body's natural GH production while keeping negative feedback mechanisms balanced. It is known for its potent appetite-stimulating effects.

Mechanism of Action

GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R1a), the same receptor activated by ghrelin. This initiates a signaling cascade in the hypothalamus and pituitary gland, triggering a rapid pulse of natural GH secretion. The released GH then signals the liver to secrete IGF-1, which promotes muscle growth and fat metabolism. GHRP-6 also stimulates ghrelin release, causing significant appetite increase.

Key Benefits

  • Potent stimulation of natural growth hormone release
  • Significant increase in appetite (beneficial for bulking/weight gain)
  • Enhanced muscle growth through elevated GH and IGF-1
  • Improved fat metabolism and body composition
  • Cardioprotective effects observed in research
  • Enhanced recovery from exercise and injury
  • Cytoprotective and anti-inflammatory properties
  • Maintains natural GH pulsatile release
Molecular Weight
873 Da
Chain Length
6 amino acids
Type
Synthetic hexapeptide
Amino Acid Sequence
One-letter: H?WAW?FK?
H₂N
H 1
O ‖ C
N
H
? 2
O ‖ C
N
W 3
O ‖ C
N
A 4
O ‖ C
N
W 5
O ‖ C
N
H
? 6
O ‖ C
N
F 7
O ‖ C
N
K 8
O ‖ C
N
H
? 9
COOH
His
1

Histidine

Position 1

D
2

D

Position 2

Trp
3

Tryptophan

Position 3

Ala
4

Alanine

Position 4

Trp
5

Tryptophan

Position 5

D
6

D

Position 6

Phe
7

Phenylalanine

Position 7

Lys
8

Lysine

Position 8

NH2
9

NH2

Position 9

N-terminus C-terminus
Hydrophobic
Polar
Positive (+)
Negative (-)
Modified

Growth Hormone Enhancement

  • GH Secretion

    Potent stimulation of endogenous growth hormone release through ghrelin receptor activation.

  • IGF-1 Elevation

    Indirectly increases IGF-1 levels through enhanced GH secretion from the pituitary.

Body Composition

  • Muscle Growth

    Enhanced muscle protein synthesis through elevated growth hormone and IGF-1 levels.

  • Appetite Stimulation

    Significant increase in hunger through ghrelin pathway activation, beneficial for those needing to gain weight.

  • Recovery Enhancement

    Faster recovery from exercise and improved tissue repair.

Protective Effects

  • Cardioprotection

    Research indicates protective effects on cardiac tissue independent of GH release.

  • Cytoprotection

    Systemic cytoprotective effects with anti-inflammatory properties observed in liver and other organs.

  • Antioxidant Effects

    Attenuation of reactive oxygen species and preservation of antioxidant defenses.

Subcutaneous injection is the primary administration route. Must be administered on an empty stomach as elevated blood glucose or insulin significantly blunts GH release. Multiple daily doses recommended.

GoalDoseFrequencyRoute
GH optimization100 mcg2-3x dailySubQ
Enhanced results200-300 mcg2-3x dailySubQ
With GHRH (synergy)100 mcg each2-3x dailySubQ (combined)
Appetite/bulking100-200 mcgBefore mealsSubQ

Reconstitution Instructions

Materials Needed:
  • Bacteriostatic water (BAC)
  • Insulin syringes (0.5-1 mL)
  • Alcohol swabs
  • Peptide vial
  • Sterile work surface
  1. 1 Clean work area and hands thoroughly
  2. 2 Calculate required BAC water volume
  3. 3 Draw BAC water into syringe
  4. 4 Inject slowly down vial side (not directly onto powder)
  5. 5 Gently swirl until dissolved (never shake)
  6. 6 Store in refrigerator, use within 28 days
CJC-1295

GHRH + GHRP combination produces synergistic GH release significantly greater than either alone.

synergistic
Mod GRF 1-29

Classic stack; GHRH amplifies GHRP-6's effects on growth hormone release.

synergistic
GHRP-2

Similar mechanism; GHRP-2 is more potent with less appetite stimulation.

compatible
Ipamorelin

Both are GHRPs; Ipamorelin has fewer side effects but is less potent.

compatible
BPC-157

No known negative interactions; often combined for recovery protocols.

compatible
Insulin

Simultaneous administration may increase GH response, but carb consumption blunts GH release.

requires timing
Immediately

Intense hunger within 15-20 minutes; GH spike within 30 minutes

Week 1-2

Improved sleep quality and increased appetite

Week 2-4

Enhanced recovery and energy levels

Week 4-8

Noticeable changes in body composition

Week 8-12

Full benefits with improved muscle fullness and fat loss

Common Side Effects

  • Intense hunger/increased appetite (most notable side effect)
  • Water retention
  • Tingling or numbness in extremities
  • Tiredness or lethargy after injection
  • Mild headache

Stop Signs - Discontinue if:

  • Severe or persistent headaches
  • Unusual swelling in hands or feet
  • Signs of carpal tunnel syndrome
  • Allergic reactions
  • Hypoglycemia symptoms

Contraindications

  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Pituitary disorders
  • Diabetes (use with caution)
  • WADA prohibited for competitive athletes

Good Signs

  • White to off-white lyophilized powder
  • Clear solution after reconstitution
  • Intact vacuum seal on vial

Warning Signs

  • Slight clumping that dissolves with gentle swirling

Bad Signs

  • Discolored or yellow powder
  • Cloudy solution after reconstitution
  • Particles or precipitates in solution
  • Effects of GHRP-6 on Weight Gain and Fat Mass
    Endocrinology (2010)

    Significant differences in body composition, muscle growth, glucose metabolism, memory and cardiac function in mice administered GHRP-6.

  • Synthetic Growth Hormone-Releasing Peptides: Cytoprotective Effects
    Clinical Medicine Insights: Cardiology (2017)

    GHRP-6 demonstrated systemic cytoprotective effects, anti-inflammatory properties, and cardioprotective effects in multiple studies.

  • GHRP-6 Clinical Safety Trial
    Clinical Research (2015)

    Intravenous administration proved safe in dose scale-up clinical trial in healthy human volunteers.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.